NAOV
NASDAQ
$4.02
NanoVibronix Inc (NAOV)
NanoVibronix Inc. is a forward-thinking medical technology company specializing in the creation of innovative, non-invasive therapeutic devices aimed at improving biological responses in wound healing, pain relief, and biofilm prevention. Based in Elmsford, New York, and operating through its subsidiary, NanoVibronix Ltd., the company harnesses advanced ultrasound technology to provide effective treatment solutions that address significant unmet clinical needs. With a strategic focus on enhancing patient outcomes, NanoVibronix is well-positioned for growth within the dynamic medical device market, appealing to institutional investors seeking opportunities in healthcare innovation.
Sector:
Healthcare
Industry:
Medical Devices
Target: $10.50 (+161.19%)
Market Cap
$15M
Revenue 5Y CAGR
+27.95%
FCF 5Y CAGR
+32.59%
Free Cash Flow Yield
-83.43%
Price Chart
Valuation
Market Cap$15M
Profitability
Total Revenue (TTM)$2.18M
Gross Profit (TTM)$806K
EBITDA-$24M
EPS-$17.25
Financial Health
Free Cash Flow Yield-83.43%
Growth & Risk
EPS 5Y CAGR-31.06%
Revenue 5Y CAGR+27.95%
FCF 5Y CAGR+32.59%
Beta (5Y)0.27
Sharpe Ratio-0.29